| Abstract | The flushing and telangiectasias associated with rosacea are notoriously difficult to treat with standard medications. Newer technologies, namely medical lasers and light sources, have made it possible to control and improve erythematotelangietatic signs of rosacea. The potassium-titanyl-phosphate laser in particular is an efficacious and safe tool for treatment of this disease. |
| Authors | Amy Miller
(Affiliation: St Louis Skin Solutions, MO 63131, USA. drmiller at stlouisskin.com)
|
| Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
2005 Nov-Dec
Vol. 4
Issue 6
Pg. 760-2
ISSN: 1545-9616 United States |
| PMID | 16302564
(Publication Type: Case Reports)
|
| Chemical References |
- Phosphates
- Radiation-Sensitizing Agents
- potassium titanylphosphate
- Titanium
|
| Topics |
- Adult
- Chronic Disease
- Humans
- Laser Therapy
- Male
- Phosphates
(therapeutic use)
- Radiation-Sensitizing Agents
(therapeutic use)
- Rosacea
(drug therapy, radiotherapy)
- Titanium
(therapeutic use)
- Treatment Outcome
|
